Uncategorized

3 Once-in-a-Decade Buying Opportunities

The S&P 500 delivered strong returns for investors over the past three years as they piled into growth stocks in a number of fields, from technology to biotech and consumer goods. And they took a particular interest in players involved in artificial intelligence (AI), seeing this area as the next big thing. This bet has been a successful one for many, as certain AI companies have already generated fantastic revenue growth and stock performance.

But, in recent weeks, the stock market has faced a variety of challenges. Investors have worried about economic factors — such as the pace of interest rate cuts — as well as the possibility that AI tools, as they accomplish new tasks, may hurt demand for the products and services of certain companies.

Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »

These and other headwinds have weighed on the S&P 500, driving it to declines over the past two weeks. But, for the long-term investor, there’s a silver lining in this cloud. The declines have left us with the following once-in-a-decade buying opportunities…

Image source: Getty Images.

Nvidia (NASDAQ: NVDA) has driven stock market gains in recent years thanks to its leadership in the AI market. The stock has soared more than 700% over the past three years as investors scrambled to get in on what they saw as the key player in the AI revolution. Nvidia designs the world’s most powerful AI chips, and as a result, major tech companies have turned to this leader for their AI projects.

This has helped the chip designer generate double-digit revenue growth in recent quarters, with revenue reaching record levels. And this has been done at high levels of profitability — gross margin has steadily exceeded 70%.

Nvidia has already established itself as an AI giant, and the company’s commitment to innovation should keep it in this valuable position. The tech player has pledged to update its chips annually, and the next release is set for later this year. This should spark a new wave of growth at that time and into 2027.

Considering this track record and likelihood of future strength, Nvidia looks dirt cheap at 23x forward earnings estimates.

Moderna (NASDAQ: MRNA) has had its share of difficult times over the past few years. The coronavirus vaccine giant once was a highflier, but when demand for that product dropped, many investors lost interest in the biotech company. Meanwhile, in more recent times, Moderna has faced a challenging vaccine policy environment. The government last year cut funding for mRNA vaccine research, and just recently, U.S. regulators said they wouldn’t review the company’s flu vaccine application.

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *